Fusion Pharmaceuticals Inc (FUSN)
21.52
+0.09
(+0.42%)
USD |
NASDAQ |
May 15, 14:44
Fusion Pharmaceuticals Market Cap: 1.830B for May 15, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 14, 2024 | 1.823B |
| May 13, 2024 | 1.823B |
| May 10, 2024 | 1.827B |
| May 09, 2024 | 1.819B |
| May 08, 2024 | 1.820B |
| May 07, 2024 | 1.820B |
| May 06, 2024 | 1.822B |
| May 03, 2024 | 1.825B |
| May 02, 2024 | 1.828B |
| May 01, 2024 | 1.822B |
| April 30, 2024 | 1.823B |
| April 29, 2024 | 1.820B |
| April 26, 2024 | 1.818B |
| April 25, 2024 | 1.816B |
| April 24, 2024 | 1.816B |
| April 23, 2024 | 1.818B |
| April 22, 2024 | 1.809B |
| April 19, 2024 | 1.804B |
| April 18, 2024 | 1.803B |
| April 17, 2024 | 1.803B |
| April 16, 2024 | 1.804B |
| April 15, 2024 | 1.806B |
| April 12, 2024 | 1.808B |
| April 11, 2024 | 1.813B |
| April 10, 2024 | 1.813B |
| Date | Value |
|---|---|
| April 09, 2024 | 1.814B |
| April 08, 2024 | 1.816B |
| April 05, 2024 | 1.809B |
| April 04, 2024 | 1.819B |
| April 03, 2024 | 1.811B |
| April 02, 2024 | 1.807B |
| April 01, 2024 | 1.803B |
| March 28, 2024 | 1.806B |
| March 27, 2024 | 1.804B |
| March 26, 2024 | 1.804B |
| March 25, 2024 | 1.794B |
| March 22, 2024 | 1.799B |
| March 21, 2024 | 1.795B |
| March 20, 2024 | 1.786B |
| March 19, 2024 | 1.794B |
| March 18, 2024 | 901.13M |
| March 15, 2024 | 846.08M |
| March 14, 2024 | 791.03M |
| March 13, 2024 | 804.58M |
| March 12, 2024 | 802.89M |
| March 11, 2024 | 797.80M |
| March 08, 2024 | 800.19M |
| March 07, 2024 | 799.39M |
| March 06, 2024 | 789.03M |
| March 05, 2024 | 836.85M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
86.78M
Minimum
Aug 11 2022
1.830B
Maximum
May 15 2024
406.09M
Average
325.73M
Median
Market Cap Benchmarks
| AstraZeneca PLC | 238.80B |
| Landos Biopharma Inc | 69.86M |
| Perspective Therapeutics Inc | 821.68M |
| Acasti Pharma Inc | 25.19M |
| Aurinia Pharmaceuticals Inc | 772.30M |
Market Cap Related Metrics
| PS Ratio | 712.17 |
| Price to Book Value | 7.569 |
| Price | 21.52 |
| Earnings Yield | -6.60% |